Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?

被引：0
|
作者：
Schaefer, Jordan K. [1 ]
Barnes, Geoffrey D. [2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2024年 / 124卷 / 08期
关键词：
WARFARIN; NONADHERENCE; MANAGEMENT; ADHERENCE;
D O I：
10.1055/s-0044-1787299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：791 / 794
页数：4
相关论文
共 50 条
  • [11] Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
    Iqbal, Hansa
    Straw, Sam
    Craven, Thomas P.
    Stirling, Katherine
    Wheatcroft, Stephen B.
    Witte, Klaus K.
    ESC HEART FAILURE, 2020, 7 (05): : 2032 - 2041
  • [12] Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Lee, Ki Hong
    Park, Hyung Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 583 - 594
  • [13] Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
    Raparelli, Valeria
    Proietti, Marco
    Cangemi, Roberto
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    Basili, Stefania
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) : 209 - 218
  • [14] The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
    Lyu, Si-qi
    Zhu, Jun
    Wang, Juan
    Wu, Shuang
    Zhang, Han
    Shao, Xing-hui
    Yang, Yan-min
    THROMBOSIS JOURNAL, 2024, 22 (01)
  • [15] Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review
    Hsu, Jonathan C.
    Freeman, James V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (02) : 301 - 310
  • [16] Efficacy and Risk of Therapy With the Vitamin K Antagonist Phenprocoumone Compared to Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation
    Gjermeni, Diona
    Kuehlkamp, Volker
    CIRCULATION, 2019, 140
  • [17] WARFARIN TIME IN THERAPEUTIC RANGE TRAJECTORIES IN POTENTIAL SWITCHERS TO DIRECT ORAL ANTICOAGULANTS
    Pundi, Krishna
    Perino, Alexander
    Fan, Jun
    Schmitt, Susan
    Kothari, Mitra
    Szummer, Karolina
    Askari, Mariam
    Heidenreich, Paul A.
    Turakhia, Mintu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 416 - 416
  • [18] Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations
    Saraf, Karan
    Morris, Paul
    Garg, Pankaj
    Sheridan, Paul
    Storey, Robert
    POSTGRADUATE MEDICAL JOURNAL, 2014, 90 (1067) : 520 - 528
  • [19] Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis
    Grace K. H. Lee
    Vanessa H. Chen
    Choon-Han Tan
    Aloysius S. T. Leow
    Wan-Yee Kong
    Ching-Hui Sia
    Nicholas W. S. Chew
    Tian-Ming Tu
    Bernard P. L. Chan
    Leonard L. L. Yeo
    Vijay K. Sharma
    Benjamin Y. Q. Tan
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 724 - 731
  • [20] Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)
    Sucker C.
    Litmathe J.
    Berthold H.K.
    MMW - Fortschritte der Medizin, 2019, 161 (Suppl 6) : 15 - 23
12345